| Autor: |
Nima Khodakarami, Marvellous A. Akinlotan, Timothy Callaghan, Kristin M. Primm, Meera Vadali, Jane Bolin, Alva O. Ferdinand |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Preventive Medicine Reports, Vol 34, Iss , Pp 102225- (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2211-3355 |
| DOI: |
10.1016/j.pmedr.2023.102225 |
| Popis: |
There has been evidence of rising HIV incidence attributable to opioid misuse within some areas of the U.S. The purpose of our study was to explore national trends in co-occurring HIV and opioid-related hospitalizations and to identify their risk factors. We used the 2009–2017 National Inpatient Sample to indicate hospitalizations with co-occurring HIV and opioid misuse diagnoses. We estimated the frequency of such hospitalizations per year. We fitted a linear regression to the annual HIV-opioid co-occurrences with year as a predictor. The resulting regression did not reveal any significant temporal changes. We used multivariable logistic regression to determine the adjusted odds (AOR) of hospitalization for co-occurring HIV and opioid-related diagnoses. The odds of hospitalization were lower for rural residents (AOR = 0.28; CI = 0.24–0.32) than urban. Females (AOR = 0.95, CI = 0.89–0.99) had lower odds of hospitalization than males. Patients identifying as White (AOR = 1.23, CI = 1.00–1.50) and Black (AOR = 1.27, CI = 1.02–1.57) had higher odds of hospitalization than other races. When compared to co-occuring hospitalizations in the Midwest, the odds were higher in the Northeast. (AOR = 2.56, CI = 2.07–3.17) Future research should explore the extent to which similar findings occur in the context of mortality and targeted interventions should intesify for subpopulations at highest risk of co-occuring HIV and opioid misuse diagnoses. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
